Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Breast Neoplasms 6Uterine Cervical Neoplasms 2Rectal Neoplasms 2Prostatic Neoplasms 2Pancreatic Neoplasms 2Multiple Myeloma 2Adenomatous Polyposis Coli 2Uterine Neoplasms 1Thrombocythemia, Essential 1Stomach Neoplasms 1Smoldering Multiple Myeloma 1Sezary Syndrome 1Radiodermatitis 1Prostate Cancer Metastatic Castration Resistant 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycythemia Vera 1Pain 1Neoplasms 1Myelodysplastic Syndromes 1Mycosis Fungoides 1Monoclonal Gammopathy of Undetermined Significance 1Lymphoma, T-Cell, Cutaneous 1Leukemia, Lymphocytic, Chronic, B-Cell 1Head and Neck Neoplasms 1Gastritis, Atrophic 1Fatigue 1Endometrial Neoplasms 1Communicable Diseases 1Colorectal Neoplasms 1

Interventions

fludarabine phosphate 17Mycophenolic Acid 17Tacrolimus 15Peripheral Blood Stem Cell Transplantation 14Whole-Body Irradiation 13Cyclophosphamide 12Cyclosporine 11Methotrexate 10Antilymphocyte Serum 10Busulfan 9Radiotherapy 6pembrolizumab 5Methylprednisolone 5Alemtuzumab 5merphos 4Transplantation 4Rituximab 4Melphalan 4Flow Cytometry 4Cord Blood Stem Cell Transplantation 4Bexarotene 4sargramostim 3Therapeutics 3Sirolimus 3Panobinostat 3Lenalidomide 3Gemcitabine 3Dexamethasone 3Cyclosporins 3zanolimumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Sezary Syndrome × Curcumin × Clear all
NCT00969085 2012-09-07

Trial of Curcumin in Cutaneous T-cell Lymphoma Patients

M.D. Anderson Cancer Center

Phase 2 Withdrawn
DermatologicLymphoid

Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡